Crossmark

Cefazolin versus fluoroquinolones for the treatment of community-acquired urinary tract infections in hospitalized patients

Crossref DOI link: https://doi.org/10.1007/s10096-019-03582-3

Published Online: 2019-05-21

Published Print: 2019-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Uppala, Amulya

King, Esther A.

Patel, Dimple
License Information

Text and Data Mining valid from 2019-05-21
More Information

Article History

Received: 11 February 2019

Accepted: 6 May 2019

First Online: 21 May 2019

Compliance to ethical standards

:

: The authors declare that they have no conflict of interest.

: This is a retrospective study that has been reviewed by the institutional review board prior (IRB) to the beginning of the study. A letter from the IRB has been attached in the supplementary section.

: Informed consent was not required for this study as it was a retrospective study and no interventions were taken that would impact patient care. In addition, informed consent was not required according to per institutional policies and no identifying details were revealed regarding patients.

: None to declare.